397 related articles for article (PubMed ID: 33713286)
21. The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification.
Cho YK; Kang YM; Yoo JH; Lee J; Lee SE; Yang DH; Kang JW; Park JY; Jung CH; Kim HK; Lee WJ
Sci Rep; 2018 Aug; 8(1):12004. PubMed ID: 30104707
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study.
Lin A; Wong ND; Razipour A; McElhinney PA; Commandeur F; Cadet SJ; Gransar H; Chen X; Cantu S; Miller RJH; Nerlekar N; Wong DTL; Slomka PJ; Rozanski A; Tamarappoo BK; Berman DS; Dey D
Cardiovasc Diabetol; 2021 Jan; 20(1):27. PubMed ID: 33514365
[TBL] [Abstract][Full Text] [Related]
23. Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).
Käräjämäki AJ; Pätsi OP; Savolainen M; Kesäniemi YA; Huikuri H; Ukkola O
PLoS One; 2015; 10(11):e0142937. PubMed ID: 26571029
[TBL] [Abstract][Full Text] [Related]
24. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes.
Käräjämäki AJ; Bloigu R; Kauma H; Kesäniemi YA; Koivurova OP; Perkiömäki J; Huikuri H; Ukkola O
Metabolism; 2017 Jan; 66():55-63. PubMed ID: 27423871
[TBL] [Abstract][Full Text] [Related]
25. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.
Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Avillach P; Egger P; Dhalwani NN; Kendrick S; Celis-Morales C; Waterworth DM; Alazawi W; Sattar N
BMJ; 2019 Oct; 367():l5367. PubMed ID: 31594780
[TBL] [Abstract][Full Text] [Related]
26. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
[TBL] [Abstract][Full Text] [Related]
27. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis.
Mantovani A; Dauriz M; Sandri D; Bonapace S; Zoppini G; Tilg H; Byrne CD; Targher G
Liver Int; 2019 Apr; 39(4):758-769. PubMed ID: 30657626
[TBL] [Abstract][Full Text] [Related]
28. Atherosclerosis and Associated Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.
Bajaj S; Prajapati SK
J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702845
[TBL] [Abstract][Full Text] [Related]
29. Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.
Yoshihisa A; Sato Y; Sato T; Suzuki S; Oikawa M; Takeishi Y
BMC Cardiovasc Disord; 2018 Jan; 18(1):11. PubMed ID: 29368593
[TBL] [Abstract][Full Text] [Related]
30. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
Muzurović E; Mikhailidis DP; Mantzoros C
Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798
[TBL] [Abstract][Full Text] [Related]
31. The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study.
Ryoo JH; Choi JM; Moon SY; Suh YJ; Shin JY; Shin HC; Park SK
Atherosclerosis; 2013 Apr; 227(2):398-403. PubMed ID: 23390894
[TBL] [Abstract][Full Text] [Related]
32. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
[TBL] [Abstract][Full Text] [Related]
33. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes.
Targher G; Mantovani A; Pichiri I; Rigolon R; Dauriz M; Zoppini G; Morani G; Vassanelli C; Bonora E
Clin Sci (Lond); 2013 Sep; 125(6):301-9. PubMed ID: 23596966
[TBL] [Abstract][Full Text] [Related]
34. A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation.
Zhou BG; Ju SY; Mei YZ; Jiang X; Wang M; Zheng AJ; Ding YB
Front Endocrinol (Lausanne); 2023; 14():1160532. PubMed ID: 37476492
[TBL] [Abstract][Full Text] [Related]
35. Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation.
Cai X; Zheng S; Liu Y; Zhang Y; Lu J; Huang Y
Liver Int; 2020 Jul; 40(7):1594-1600. PubMed ID: 32279432
[TBL] [Abstract][Full Text] [Related]
36. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study.
Zhang T; Zhang C; Zhang Y; Tang F; Li H; Zhang Q; Lin H; Wu S; Liu Y; Xue F
Atherosclerosis; 2015 May; 240(1):144-8. PubMed ID: 25785362
[TBL] [Abstract][Full Text] [Related]
37. The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study.
Chen YG; Yang CW; Chung CH; Ho CL; Chen WL; Chien WC
Hepatol Int; 2022 Aug; 16(4):807-816. PubMed ID: 35064545
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants.
Pastori D; Menichelli D; Del Sole F; Pignatelli P; Violi F;
Mayo Clin Proc; 2021 Mar; 96(3):658-665. PubMed ID: 33308867
[TBL] [Abstract][Full Text] [Related]
39. Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation.
Polovina M; Hindricks G; Maggioni A; Piepoli M; Vardas P; Ašanin M; Ðikic D; Ðuricic N; Milinkovic I; Seferovic PM
Eur Heart J; 2018 Dec; 39(45):4030-4039. PubMed ID: 30101326
[TBL] [Abstract][Full Text] [Related]
40. The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome.
Cho KI; Jo EA; Cho SH; Kim BH
Metab Syndr Relat Disord; 2017 Jun; 15(5):226-232. PubMed ID: 28346857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]